XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Deficit)
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Stockholders' Equity (Deficit)
7. Stockholders’ Equity (Deficit)
Redeemable Convertible Preferred Stock
Prior to its conversion to common stock in December 2020, the Company’s redeemable convertible preferred stock was classified as mezzanine equity on the Company’s balance sheets as the shares are contingently redeemable upon a deemed liquidation such as a change in control and in that event, there is no guarantee that all stockholders would be entitled to receive the same form of consideration. No accretion to redemption value was recorded during the three months ended March 31, 2020 as a deemed liquidation event was not considered probable.
In March 2020, the Company issued 14,701,054
shares of its Series B redeemable convertible preferred stock, including
4,673,388
shares issued upon conversion of then outstanding convertible notes and accrued interest, and
10,027,666
shares issued for cash at a purchase price of
$2.16
per share, resulting in gross proceeds of $21.5 million. The Series B purchase agreement provided that the Company would issue, and the Series B holders would purchase, an additional
21,732,862
shares of the Company’s Series B redeemable convertible preferred stock across two tranches for aggregate proceeds of
$46.9 
million in the event that certain agreed upon milestones were achieved or the preferred majority approved their closing. As of March 31, 2020, these future Series B tranches did not meet the definition of freestanding instruments or the definition of derivatives, therefore, they were not accounted for separately or bifurcated.
Common Stock
The Company has reserved shares of common stock for the following potential future issuances:
 
                                         
    
March 31,
    
December 31,
 
    
2021
    
2020
 
Shares underlying outstanding equity awards
     6,308,582        6,316,569  
Shares available for future equity award grants
     3,152,910        1,506,806  
Shares underlying early exercised equity awards
     76,293        100,263  
Shares underlying ESPP withholdings
     19,126        4,393  
Total
     9,556,911        7,928,031